Home
About
Contact
DISCLAIMER: This site is for informational purposes only. While we make every effort to keep it up to date, there is no guarantee that information is complete, accurate, comprehensive, or the same for all KP regions. The information on this site should not be interpreted or used as a substitute for professional medical care. Please consult your care provider for any personal health questions or before participating in clinical trials.
Search Results
Tip
Select Recruitment Status
Active, not yet recruiting
Active, currently enrolling
Active, enrolling only by invitation
Enrollment complete
Study completed
Enrollment on hold
Study terminated early
Select Study Type
INTERVENTIONAL
OBSERVATIONAL
Select Clinical Trial Type
Phase I
Phase II
Phase IIA
Phase IIB
Phase III
Phase IV
n/a
Select Clinical Area
Adolescent Medicine
Addiction Medicine
Allergy and Immunology
Anesthesiology
Cardiology
Complimentary and Alternative Med
Dermatology
Emergency Medicine
Endocrinology, Diabetes and Metabolism
Epidemiology
Family Medicine
Genetics
Geriatric Medicine
Gastroenterology
Hematology
Infectious Diseases
Internal Medicine
Nephrology
Lifestyle Medicine
Neurology/Neurological Disorders
Nuclear Medicine
Nursing
Obstetrics and Gynecology
Occupational Medicine
Oncology (Adult)
Oncology (Pediatrics)
Ophthalmology
Other
Otolaryngology/ENT
Pediatrics
Physical Medicine and Rehabilitation
Podiatric Medicine
Preventative Medicine
Psychiatry
Pulmonary Disease
Radiology
Rheumatology
Sports Medicine
Surgery (Colon and Rectal)
Surgery (General)
Surgery (Hand)
Surgery (Neurological)
Surgery (Orthopedic)
Surgery (Plastic)
Surgery (Thoracic)
Surgery (Urology)
Surgery (Vascular)
Urology
Select Regions
California - Northern
California - Southern
Colorado
Georgia
Hawaii
Mid-Atlantic
Northwest
Washington
Select Facility 1
Select Facility 2
Select Facility 3
Male
Female
Child (Birth - 17 yrs)
Adult (18 - 65 yrs)
Senior (66 and above)
Saved Studies
You currently don’t have any saved studies. To save a study, select the bookmark icon on the result listing.
Active, currently enrolling
Who can join
Connect for Cancer Prevention Study: A Prospective Cohort Study Within Integrated Healthcare Systems in the US
Keywords:
Risk Factors; Medical Conditions; Pathology; Blood; Urine; Natural History
Study Type:
Prospective Cohort Study with Direct Patient Contact |
Region:
Georgia
Active, currently enrolling
Who can join
A Phase 3, Randomized, Open-label Study of MK-5684 Versus Alternative Abiraterone Acetate or Enzalutamide in Participants with Metastatic Castration-resistant Prostate Cancer (mCRPC) That Progressed On or After Prior Treatment with One Nextgeneration Hormonal Agent (NHA)
Keywords:
Oncology (Adult); Genital Neoplasms, Male; Urogenital Neoplasms; Neoplasms by…
Study Type:
Clinical Trial |
Region:
California - Northern
Enrollment complete
Who can join
CASPAR - A Phase III Trial of Enzalutamide and Rucaparib as a Novel Therapy in First-Line Metastatic Castration-Resistant Prostate Cancer
Keywords:
Oncology (Adult);Urology; Genital Neoplasms, Male; Urogenital…
Study Type:
Clinical Trial |
Region:
California - Northern
Active, currently enrolling
Who can join
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Keywords:
Prostatic Neoplasms; Genital Neoplasms; Male; Urogenital Neoplasms; Neoplasms by…
Study Type:
INTERVENTIONAL |
Region:
California - Northern
Active, not yet recruiting
Who can join
A Prospective, Open-Label, Randomized, Phase 3 Trial of Acasunlimab (GEN1046) in Combination With Pembrolizumab Versus Docetaxel in Subjects With PD-L1 Positive Metastatic Non-Small Cell Lung Cancer After Treatment With a PD-1/PD-L1 Inhibitor and Platinum-Containing Chemotherapy (ABBIL1TY NSCLC-06)
Keywords:
Oncology (Adult);
Study Type:
INTERVENTIONAL |
Region:
Hawaii
Active, currently enrolling
Who can join
A Phase 3 Study of Fixed Dose Combinations of Fianlimab and Cemiplimab Versus Relatlimab and Nivolumab in Participants With Unresectable or Metastatic Melanoma
Keywords:
Unresectable Melanoma; Metastatic Melanoma; Advanced Melanoma; Stage III; Stage…
Study Type:
INTERVENTIONAL |
Region:
Northwest
Active, currently enrolling
Who can join
Melanoma Margins Trial-II - A Phase III, Multi-centre Randomised Controlled Trial Investigating 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma (02.18 MelMarT-II)
Keywords:
Malignant; Melanoma; Cancer; Surgery; Oncology (Adult);Surgery (General);
Study Type:
INTERVENTIONAL |
Region:
Northwest
Active, currently enrolling
Who can join
A Phase 3 Randomized Study of Loncastuximab Tesirine Combined With Rituximab Versus Immunochemotherapy in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (LOTIS-5)
Keywords:
Loncastuximab Tesirine; Refractory Diffuse Large B-Cell Lymphoma; Relapsed…
Study Type:
INTERVENTIONAL |
Region:
Northwest
Active, currently enrolling
Who can join
Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)
Keywords:
Carcinoma, Carcinoma, Renal Cell, Neoplasms, Glandular and Epithelial, Neoplasms…
Study Type:
INTERVENTIONAL |
Region:
Northwest
Active, currently enrolling
Who can join
Prospective Evaluation of Carvedilol in Prevention of Cardiac Toxicity in Patients With Metastatic HER-2+ Breast Cancer, Phase III (S1501)
Keywords:
Oncology (Adult); S1501; Breast Neoplasms; Neoplasms; Cardiotoxicity; Neoplasms…
Study Type:
INTERVENTIONAL |
Region:
Northwest
1
2
3
4
5
6
7
8
9
10
...